Safety Pharmacology of Soap: A Comprehensive Review of Dermal, Systemic, Ocular, and Environmental Considerations

Abstract

Soap is one of the most widely used personal hygiene products across the world and plays a crucial role in maintaining skin cleanliness and preventing infectious diseases. Due to its frequent and long-term use, evaluation of its safety is of paramount importance. Safety pharmacology involves the systematic study of potential adverse effects of substances on biological systems. In the context of soap, safety pharmacology primarily focuses on dermal safety, systemic absorption, ocular safety, toxicity profile, microbial safety, and environmental impact. Modern soap formulations contain various additives such as surfactants, fragrances, preservatives, and antimicrobial agents, which require thorough toxicological assessment. This article provides a comprehensive review of the safety pharmacology of soap, highlighting regulatory guidelines, experimental studies, and clinical evidence supporting its safe use. The findings suggest that soaps are generally safe when formulated according to regulatory standards and used as intended.

Keywords

Introduction

Soap is an indispensable personal hygiene product that has been used for centuries for cleansing the skin and preventing the spread of infectious diseases. Chemically, soaps are sodium or potassium salts of fatty acids produced by the saponification of fats and oils. The cleansing action of soap is attributed to its surfactant properties, which enable the removal of dirt, sebum, and microorganisms from the skin surface¹. In recent decades, increased awareness regarding hygiene, infection control, and skin health has significantly increased the frequency of soap usage across all age groups. During global public health emergencies, such as viral outbreaks, handwashing with soap has been strongly recommended as a primary preventive measure². As a result, human exposure to soap products has become frequent, repetitive, and long-term. Safety pharmacology is a discipline that evaluates the potential adverse effects of substances on vital physiological systems. Although soaps are not classified as therapeutic drugs, their repeated dermal exposure necessitates a comprehensive safety pharmacological evaluation. Unlike pharmaceuticals, soaps are used without medical supervision and often multiple times daily, increasing the importance of ensuring their safety³. Modern soap formulations contain not only fatty acid salts but also surfactants, moisturizers, fragrances, preservatives, antioxidants, and antimicrobial agents. Each of these components may interact with the skin barrier and underlying tissues. Therefore, safety pharmacology of soap focuses on dermal tolerance, systemic absorption, ocular safety, toxicity profile, and long-term effects^4,5.

Fig. No. 1

2. CLASSIFICATION

Soaps can be classified based on formulation, application, and functional properties.

Based on physical form: Soaps are classified into solid bar soaps, liquid soaps, foam soaps, and synthetic detergent (syndet) bars. Syndets differ from traditional soaps in that they are formulated using synthetic surfactants and generally exhibit better skin compatibility^6.

Based on application:  Soaps are categorized as toilet soaps, medicated soaps, baby soaps, and industrial soaps. Toilet soaps are designed for routine cleansing, while medicated soaps contain active pharmaceutical ingredients such as antibacterial or antifungal agents. Baby soaps are specifically formulated to minimize irritation and maintain skin moisture due to the delicate nature of infant skin⁷.

Soaps may also be classified based on ingredient source into natural soaps and synthetic soaps. Natural soaps are derived from plant or animal fats, whereas synthetic soaps contain laboratory-produced surfactants. Each category presents distinct safety considerations depending on ingredient composition and exposure patterns⁸.

3. SAFETY PHARMACOLOGY OF SOAP

3.1 Dermal Safety

Dermal safety is the most critical component of soap safety pharmacology, as the skin is the primary site of exposure. The skin acts as a protective barrier; however, repeated exposure to cleansing agents can disrupt the stratum corneum, leading to dryness, irritation, and compromised barrier function⁹. Traditional alkaline soaps can remove natural lipids from the skin, resulting in increased transepidermal water loss. This may cause dryness, erythema, and irritation, particularly in individuals with sensitive skin or dermatological conditions such as eczema^10.

To enhance dermal safety, modern soaps incorporate mild surfactants, emollients, and humectants such as glycerin. These ingredients help maintain skin hydration and reduce irritation. Dermal safety is evaluated through standardized tests including primary skin irritation tests, patch testing, and repeated insult patch tests in human volunteers^11,12. Clinical studies have demonstrated that well-formulated soaps do not produce significant adverse dermal effects when used under normal conditions. However, misuse or excessive washing with harsh soaps may contribute to skin barrier damage¹³.

Fig.No. 2

Fig. No. 3

Fig. No. 4

In addition, mutagenicity, carcinogenicity, and reproductive toxicity studies conducted on approved soap ingredients have shown no significant risk at consumer exposure levels. Regulatory toxicological evaluations consistently confirm that soaps are safe when used according to recommended conditions^24.

3.5 Microbial Safety

Microbial safety is a key consideration in the safety pharmacology of soap, particularly due to its role in infection prevention. Regular soaps remove microorganisms primarily through mechanical action rather than direct antimicrobial activity²⁵. Antimicrobial soaps contain active ingredients such as chlorhexidine, triclocarban, or herbal antimicrobial agents. While these soaps may offer enhanced microbial reduction, safety pharmacology assessment ensures that their active components do not disrupt the normal skin microbiota or promote antimicrobial resistance^26.

Studies have shown that excessive use of antimicrobial soaps may alter the natural balance of skin flora, potentially leading to irritation or colonization by resistant organisms. Consequently, regulatory authorities recommend careful evaluation and restricted use of antimicrobial agents in soap formulations^27.

3.6 pH Compatibility

The pH of soap plays a crucial role in maintaining skin health. Human skin possesses a natural acidic pH, commonly referred to as the “acid mantle,” which protects against microbial invasion and maintains barrier function²⁸. Traditional soaps are alkaline, with pH values ranging from 9 to 10. Repeated exposure to alkaline products may disrupt the acid mantle, leading to dryness, irritation, and increased susceptibility to infections²⁹. Modern soap formulations aim to achieve pH values closer to that of the skin, typically between 5.5 and 7. This pH adjustment significantly improves skin compatibility and reduces adverse dermatological effects, particularly in sensitive populations such as infants and elderly individuals ^30.

3.7 Long-Term Use Safety

Long-term use safety assessment evaluates the effects of repeated and prolonged exposure to soap products. Given the daily and lifelong use of soap, understanding its long-term impact is essential in safety pharmacology³¹. Clinical and epidemiological studies indicate that regular use of mild soaps does not result in cumulative toxicity or permanent skin damage. However, frequent use of harsh or highly alkaline soaps may exacerbate chronic skin conditions such as atopic dermatitis or contact eczema. Long-term safety is enhanced by the use of moisturizers, reduced fragrance content, and mild surfactants in soap formulations. Consumer education regarding appropriate soap selection and usage also contributes to minimizing adverse effects^32.

3.8 Safety of Additives

Soap formulations commonly include additives such as fragrances, preservatives, colorants, antioxidants, and antimicrobial agents. While these additives improve product stability, aesthetics, and functionality, they may also influence safety. Fragrances are among the most frequent causes of allergic contact dermatitis. Safety pharmacology assessment includes allergen screening and concentration limits to minimize sensitization risks³³. Preservatives such as parabens, phenoxyethanol, and organic acids are evaluated for toxicity, endocrine effects, and allergenicity. Regulatory agencies strictly control permissible concentrations to ensure consumer safety. Each additive is assessed individually and in combination to ensure that the final formulation does not produce adverse pharmacological or toxicological effects³⁴.

3.9 Environmental and User Safety

Environmental safety is an indirect but important aspect of user safety. Soap ingredients released into wastewater systems may affect aquatic ecosystems and water quality^35.

Biodegradability studies ensure that soap components break down into non-toxic byproducts. Environmentally persistent substances may accumulate and indirectly affect human health through contaminated water or food chains. The adoption of eco-friendly surfactants, biodegradable ingredients, and sustainable manufacturing practices enhances both environmental protection and long-term consumer safety³⁶.

CONCLUSION

The safety pharmacology of soap demonstrates that soap is a safe and effective cleansing agent when formulated and used according to established regulatory standards. Comprehensive evaluation of dermal safety, systemic absorption, ocular safety, toxicity profile, microbial safety, and additive safety confirms its suitability for routine and long-term use. Advancements in formulation science, continuous toxicological assessment, and strict regulatory oversight ensure that modern soaps provide effective hygiene without compromising human health. Ongoing research remains essential to address emerging concerns and improve safety further.

REFERENCES

1. World Health Organization. Guidelines on cosmetic product safety. Geneva: WHO Press; 2018. p. 1–82.
2. European Commission, Scientific Committee on Consumer Safety (SCCS). Notes of guidance for the testing of cosmetic ingredients and their safety evaluation. 10th rev. Brussels: European Union; 2018. p. 1–182.
3. U.S. Food and Drug Administration. Soap and detergent regulations and guidance. Silver Spring (MD): FDA; 2017. p. 1–45.
4. Centers for Disease Control and Prevention. Guideline for hand hygiene in health-care settings. MMWR Recomm Rep. 2002;51(RR-16):1–44.
5. Barel AO, Paye M, Maibach HI, editors. Handbook of cosmetic science and technology. 4th ed. Boca Raton (FL): CRC Press; 2014. p. 85–140.
6. Walters KA. Dermatological and transdermal formulations. New York: CRC Press; 2002. p. 215–268.
7. Lodén M, Maibach HI, editors. Dry skin and moisturizers: chemistry and function. Boca Raton (FL): CRC Press; 2000. p. 3–25.
8. Fluhr JW, Elias PM. Stratum corneum pH: formation and function of the “acid mantle”. Exog Dermatol. 2002;1(4):163–175.
9. Lambers H, Piessens S, Bloem A, Pronk H, Finkel P. Natural skin surface pH is on average below 5, which is beneficial for its resident flora. Int J Cosmet Sci. 2006;28(5):359–370.
10. Korting HC, Schmid MH, Kerscher MJ. Antimicrobial activity of skin pH. Clin Dermatol. 1996;14(1):23–27.
11. Ananthapadmanabhan KP, Moore DJ, Subramanyan K, Misra M, Meyer F. Cleansing without compromise: the impact of cleansers on the skin barrier. J Cosmet Sci. 2004;55(2):153–170.
12. Basketter DA, York M, McFadden JP, Robinson MK. Determination of skin irritation potential. Contact Dermatitis. 2004;50(2):89–94.
13. Proksch E, Brandner JM, Jensen JM. The skin: an indispensable barrier. Exp Dermatol. 2008;17(12):1063–1072.
14. Flynn GL. Physiochemical determinants of skin absorption. J Pharm Sci. 1990;79(1):1–15.
15. Wester RC, Maibach HI. Percutaneous absorption in humans. Clin Pharmacokinet. 1992;23(4):253–266.
16. Roberts MS, Walters KA. Dermal absorption and toxicity assessment. Toxicol Sci. 2008;102(1):3–10.
17. World Health Organization. Environmental health criteria: surfactants and detergents. Geneva: WHO; 1996. p. 1–120.
18. Grant WM. Toxicology of the eye. 3rd ed. Springfield (IL): Charles C Thomas; 1986. p. 210–265.
19. OECD. Test guideline 405: acute eye irritation/corrosion. Paris: OECD Publishing; 2012. p. 1–17.
20. McCulley JP. Ocular toxicity of topical agents. Surv Ophthalmol. 1984;28(5):308–318.
21. Hayes AW. Principles and methods of toxicology. 6th ed. Boca Raton (FL): CRC Press; 2014. p. 45–98.
22. Klaassen CD, editor. Casarett and Doull’s toxicology: the basic science of poisons. 9th ed. New York: McGraw-Hill; 2019. p. 23–67.
23. Williams GM, Kroes R, Munro IC. Safety evaluation of cosmetic ingredients. Food Chem Toxicol. 2009;47(2):S1–S10.
24. Cosmetic Ingredient Review Expert Panel. Final report on the safety assessment of surfactants. Int J Toxicol. 2013;32(1 Suppl):5S–85S.
25. Bloomfield SF, Aiello AE, Cookson B, O’Boyle C, Larson EL. The effectiveness of hygiene procedures. J Appl Microbiol. 2007;103(3):144–152.
26. Levy SB. Antibacterial household products. Clin Infect Dis. 2001;33(Suppl 3):S137–S142.
27. U.S. Food and Drug Administration. Safety and effectiveness of consumer antiseptic washes. Fed Regist. 2016;81(172):61106–61130.
28. Schmid-Wendtner MH, Korting HC. The pH of the skin surface. Skin Pharmacol Physiol. 2006;19(6):296–302.
29. Elias PM. Skin barrier repair. J Clin Invest. 2007;117(4):930–932.
30. Eichenfield LF, Fowler JF, Rigel DS, Taylor SC. Optimizing skin care. Pediatrics. 2009;123(6):e123–e128.
31. Loden M. Role of topical emollients. Br J Dermatol. 2003;149(3):12–17.
32. Johansen JD, Frosch PJ, Lepoittevin JP. Contact dermatitis. 5th ed. Berlin: Springer; 2011. p. 245–312.
33. Rastogi SC, Johansen JD, Menné T. Fragrance allergens. Contact Dermatitis. 1999;41(1):1–10.
34. Darbre PD. Underarm cosmetics and breast cancer. J Appl Toxicol. 2003;23(2):89–95.
35. Ying GG. Fate and behaviour of surfactants. Chemosphere. 2006;65(6):927–940.
36. Singer MM, Tjeerdema RS. Fate and effects of surfactants. Environ Toxicol Chem. 1993;12(4):709–730.